Methods and monitoring of treatment with a wnt pathway inhibitor

作者: Jacob Dupont , Robert Joseph Stagg

DOI:

关键词:

摘要: Methods for treating diseases such as cancer comprising administering a Wnt pathway inhibitor, either alone or in combination with other anti-cancer agents, and monitoring skeletal-related side effects and/or toxicity.

参考文章(466)
Hendrik Uyttendaele, Jan Kitajewski, Angiogenic modulation by notch signal transduction ,(1999)
Timothy W. Austin, Gregg P. Solar, Francis C. Ziegler, Linda Liem, William Matthews, A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood. ,vol. 89, pp. 3624- 3635 ,(1997) , 10.1182/BLOOD.V89.10.3624
David J. Van Den Berg, Arun K. Sharma, Edward Bruno, Ron Hoffman, Role of Members of the Wnt Gene Family in Human Hematopoiesis Blood. ,vol. 92, pp. 3189- 3202 ,(1998) , 10.1182/BLOOD.V92.9.3189
Hans E. Kaiser, Bela Bodey, Stuart E. Siegel, Failure of cancer vaccines : The significant limitations of this approach to immunotherapy Anticancer Research. ,vol. 20, pp. 2665- 2676 ,(2000)
Lisa J. Garrard, Dennis J. Henner, James A. Wells, Henry B. Lowman, Steven Bass, David J. Matthews, Ronald Greene, Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants ,(1991)
Duncan L. McVey, Alena Lizonova, Joseph T. Bruder, Douglas E. Brough, Imre Kovesdi, Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus ,(1996)
Yiping Yang, James M. Wilson, Giorgio Trinchieri, Method of reducing an immune response to a recombinant virus ,(2001)